{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:20:32Z","timestamp":1792185632289,"version":"4.4.0"},"reference-count":121,"publisher":"Elsevier","isbn-type":[{"value":"9780443295188","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006706","name":"Tampereen Tuberkuloosis\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014714","name":"Finnish Film Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.enz.2024.05.012","type":"book-chapter","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T07:40:54Z","timestamp":1722930054000},"page":"343-381","source":"Crossref","is-referenced-by-count":17,"title":["Mycobacterial \u03b2-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies"],"prefix":"10.1016","author":[{"given":"Jenny","family":"Parkkinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratul","family":"Bhowmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martti","family":"Tolvanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Parkkila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Aspatwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/jb.172.1.116-124.1990","article-title":"The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria","volume":"172","author":"Stahl","year":"1990","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2012.09.019","article-title":"Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media","volume":"75","author":"Kim","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"10","key":"10.1016\/bs.enz.2024.05.012_bib3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ng.2744","article-title":"Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans","volume":"45","author":"Comas","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0010005","article-title":"Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis","volume":"1","author":"Gutierrez","year":"2005","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.012_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1128\/iai.64.3.683-690.1996","article-title":"Immunopathology of tuberculosis: roles of macrophages and monocytes","volume":"64","author":"Fenton","year":"1996","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/bs.enz.2024.05.012_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.012_bib7","unstructured":"World Health Organization and (WHO), Global Tuberculosis Report, 2023, pp. 1\u2013232. ISBN 978-92-4-008385-1."},{"key":"10.1016\/bs.enz.2024.05.012_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147704","article-title":"Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19","volume":"14","author":"Gong","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/bs.enz.2024.05.012_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/bs.enz.2024.05.012_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.toxlet.2020.01.018","article-title":"Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicin","volume":"322","author":"Combrink","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/bs.enz.2024.05.012_bib11","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3389\/fmicb.2020.01644","article-title":"Two novel katG mutations conferring isoniazid resistance in Mycobacterium tuberculosis","volume":"11","author":"Hsu","year":"2020","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.012_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to rifampicin: a review","volume":"67","author":"Goldstein","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"3","key":"10.1016\/bs.enz.2024.05.012_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijtb.2019.11.012","article-title":"Irreversible neuropathy in extremely-drug resistant tuberculosis: an unfortunate clinical conundrum","volume":"67","author":"Saroha","year":"2020","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/bs.enz.2024.05.012_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fmicb.2020.00781","article-title":"Detecting ethambutol resistance in Mycobacterium tuberculosis isolates in China: a comparison between phenotypic drug susceptibility testing methods and DNA sequencing of embAB","volume":"11","author":"Li","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41467-019-14238-3","article-title":"The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/bs.enz.2024.05.012_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236109","article-title":"The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis","volume":"15","author":"Kwon","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/bs.enz.2024.05.012_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jgar.2020.02.019","article-title":"Prevalence and molecular characterization of amikacin resistance among Mycobacterium tuberculosis clinical isolates from southern China","volume":"22","author":"Islam","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/bs.enz.2024.05.012_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2180-14-165","article-title":"Molecular characterization of amikacin, kanamycin and capreomycin resistance in M\/XDR-TB strains isolated in Thailand","volume":"14","author":"Sowajassatakul","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/bs.enz.2024.05.012_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101985","article-title":"Molecular analysis of streptomycin-resistance associating genes in Mycobacterium tuberculosis isolates from Nepal","volume":"125","author":"Shrestha","year":"2020","journal-title":"Tuberculosis (Edinb.)"},{"issue":"11","key":"10.1016\/bs.enz.2024.05.012_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/138955707782331740","article-title":"Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms","volume":"7","author":"Shi","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"issue":"7","key":"10.1016\/bs.enz.2024.05.012_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","article-title":"Fluoroquinolones, tuberculosis, and resistance","volume":"3","author":"Ginsburg","year":"2003","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40265-018-1043-y","article-title":"The role of fluoroquinolones in the treatment of tuberculosis in 2019","volume":"79","author":"Pranger","year":"2019","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/bs.enz.2024.05.012_bib23","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/jac\/dkx316","article-title":"Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis","volume":"72","author":"Chen","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053162","article-title":"Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues","volume":"8","author":"Coxon","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.enz.2024.05.012_bib25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5588\/ijtld.16.0498","article-title":"Carbapenems against Mycobacterium tuberculosis: a review of the evidence","volume":"20","author":"Jaganath","year":"2016","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.012_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02234-16","article-title":"Mutation in an unannotated protein confers carbapenem resistance in Mycobacterium tuberculosis","volume":"61","author":"Kumar","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.enz.2024.05.012_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2147\/IDR.S200697","article-title":"Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis","volume":"12","author":"Zhang","year":"2019","journal-title":"Infect. Drug. Resist."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.012_bib28","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1128\/AAC.00647-15","article-title":"Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance","volume":"59","author":"Minato","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.enz.2024.05.012_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100037","article-title":"Tuberculosis: past, present and future of the treatment and drug discovery research","volume":"2","author":"Bendre","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug. Discov."},{"key":"10.1016\/bs.enz.2024.05.012_bib30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug. Des. Devel. Ther."},{"issue":"12","key":"10.1016\/bs.enz.2024.05.012_bib31","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1093\/cid\/ciaa755","article-title":"Delamanid resistance: update and clinical management","volume":"71","author":"Nguyen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/bs.enz.2024.05.012_bib32","first-page":"779","article-title":"The role of delamanid in the treatment of drug-resistant tuberculosis","volume":"11","author":"Lewis","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01948-20","article-title":"Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis","volume":"65","author":"Rifat","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"101","key":"10.1016\/bs.enz.2024.05.012_bib34","doi-asserted-by":"crossref","first-page":"57823","DOI":"10.1039\/C4RA07953A","article-title":"Charge density distribution and electrostatic interactions of ethionamide: an inhibitor of the enoyl acyl carrier protein reductase (inhA) enzyme of Mycobacterium tuberculosis","volume":"4","author":"Rajalakshmi","year":"2014","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/bs.enz.2024.05.012_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities","volume":"2","author":"Vilch\u00e8ze","year":"2014","journal-title":"Microbiol. Spectr."},{"issue":"7","key":"10.1016\/bs.enz.2024.05.012_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00537-20","article-title":"Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis in Mongolia","volume":"64","author":"Narmandakh","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.enz.2024.05.012_bib37","doi-asserted-by":"crossref","first-page":"1100488","DOI":"10.3389\/fphar.2023.1100488","article-title":"Clofazimine for the treatment of tuberculosis","volume":"14","author":"Stadler","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib38","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/jac\/dkaa136","article-title":"Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid","volume":"75","author":"Kadura","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.012_bib39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1164\/ajrccm\/147.5.1311","article-title":"When tuberculosis treatment fails. A social behavioral account of patient adherence","volume":"147","author":"Sumartojo","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"9728","key":"10.1016\/bs.enz.2024.05.012_bib40","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.enz.2024.05.012_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in India","volume":"54","author":"Udwadia","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.012_bib42","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/AAC.38.9.2054","article-title":"Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis","volume":"38","author":"Wayne","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.012_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0966-842X(98)01216-5","article-title":"Mechanisms of latency in Mycobacterium tuberculosis","volume":"6","author":"Parrish","year":"1998","journal-title":"Trends Microbiol."},{"issue":"6685","key":"10.1016\/bs.enz.2024.05.012_bib44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"issue":"19","key":"10.1016\/bs.enz.2024.05.012_bib45","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/092986708785132906","article-title":"New anti-tuberculosis drugs with novel mechanisms of action","volume":"15","author":"Rivers","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.012_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.353","article-title":"Mycobacterium tuberculosis: pathogenesis and therapeutic targets","volume":"4","author":"Yang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/bs.enz.2024.05.012_bib47","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00018.2021","article-title":"Carbonic anhydrases in metazoan model organisms: molecules, mechanisms, and physiology","author":"Aspatwar","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/bs.enz.2024.05.012_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2199-11-25","article-title":"Phylogeny and expression of carbonic anhydrase-related proteins","volume":"11","author":"Aspatwar","year":"2010","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/bs.enz.2024.05.012_bib49","article-title":"Bicarbonate and bacteria: friends or foes?","author":"Aspatwar","year":"2024","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1113\/JP283579","article-title":"Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease","volume":"601","author":"Aspatwar","year":"2023","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084342","article-title":"Roles of carbonic anhydrases and carbonic anhydrase related proteins in zebrafish","volume":"23","author":"Aspatwar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/bs.enz.2024.05.012_bib53","series-title":"Carbonic Anhydrases","first-page":"449","article-title":"Chapter 20\u2014Carbonic anhydrases from pathogens: protozoan CAs and related inhibitors as potential antiprotozoal agents","author":"Aspatwar","year":"2019"},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2295398","article-title":"Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review","volume":"55","author":"Qureshi","year":"2023","journal-title":"Ann. Med."},{"issue":"20","key":"10.1016\/bs.enz.2024.05.012_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205153","article-title":"Mycobacterium tuberculosis beta-carbonic anhydrases: novel targets for developing antituberculosis drugs","volume":"20","author":"Aspatwar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.012_bib56","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1021\/jm9003126","article-title":"Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis","volume":"52","author":"Nishimori","year":"2009","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib57","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1021\/jm9000488","article-title":"Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate","volume":"52","author":"Minakuchi","year":"2009","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/bs.enz.2024.05.012_bib58","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmcl.2009.10.009","article-title":"Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c","volume":"19","author":"Carta","year":"2009","journal-title":"Bioorg Med. Chem. Lett."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib59","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1074\/jbc.M510756200","article-title":"Structural mechanics of the pH-dependent activity of beta-carbonic anhydrase from Mycobacterium tuberculosis","volume":"281","author":"Covarrubias","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010022","article-title":"An update on the metabolic roles of carbonic anhydrases in the model alga Chlamydomonas reinhardtii","volume":"8","author":"Aspatwar","year":"2018","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib61","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/14756366.2017.1332056","article-title":"beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis","volume":"32","author":"Aspatwar","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/bs.enz.2024.05.012_bib62","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/jac\/dkt273","article-title":"In silico analyses for the discovery of tuberculosis drug targets","volume":"68","author":"Chung","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/bs.enz.2024.05.012_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.03.028","article-title":"Anti-tubercular drug discovery: in silico implications and challenges","volume":"104","author":"Mehra","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.012_bib64","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12272-017-0914-1","article-title":"QSAR based therapeutic management of M. tuberculosis","volume":"40","author":"Ahamad","year":"2017","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib65","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1039\/C4MD00216D","article-title":"Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects","volume":"6","author":"Cort\u00e9s-Ciriano","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/bs.enz.2024.05.012_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1265573","article-title":"Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study","volume":"14","author":"Bhowmik","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/bs.enz.2024.05.012_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141076","article-title":"Combining metabolite-based pharmacophores with bayesian machine learning models for Mycobacterium tuberculosis drug discovery","volume":"10","author":"Ekins","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/bs.enz.2024.05.012_bib68","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/jcc.26712","article-title":"Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies","volume":"42","author":"Rajasekhar","year":"2021","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.012_bib69","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/092986711795029519","article-title":"Molecular dynamics simulations of protein targets identified in Mycobacterium tuberculosis","volume":"18","author":"de Azevedo","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"6294","key":"10.1016\/bs.enz.2024.05.012_bib70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/347631a0","article-title":"Molecular dynamics simulations in biology","volume":"347","author":"Karplus","year":"1990","journal-title":"Nature"},{"issue":"13","key":"10.1016\/bs.enz.2024.05.012_bib71","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1073\/pnas.1130426100","article-title":"The complete genome sequence of Mycobacterium bovis","volume":"100","author":"Garnier","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2024.05.012_bib72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fmicb.2018.00067","article-title":"Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera","volume":"9","author":"Gupta","year":"2018","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/bs.enz.2024.05.012_bib73","doi-asserted-by":"crossref","DOI":"10.1099\/ijsem.0.004922","article-title":"Reconstituting the genus Mycobacterium","volume":"71","author":"Meehan","year":"2021","journal-title":"Int. J. Syst. Evol. Microbiol."},{"issue":"D1","key":"10.1016\/bs.enz.2024.05.012_bib74","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1093\/nar\/gkad1044","article-title":"Database resources of the National Center for Biotechnology Information","volume":"52","author":"Sayers","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/bs.enz.2024.05.012_bib75","article-title":"Exploration of 3-aryl pyrazole-tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors","volume":"356","author":"Ommi","year":"2023","journal-title":"Arch. Pharm. (Weinh.)"},{"issue":"19","key":"10.1016\/bs.enz.2024.05.012_bib76","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1074\/jbc.M414348200","article-title":"Structure and function of carbonic anhydrases from Mycobacterium tuberculosis","volume":"280","author":"Suarez Covarrubias","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/bs.enz.2024.05.012_bib77","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/febs.13313","article-title":"Chemical probing suggests redox-regulation of the carbonic anhydrase activity of mycobacterial Rv1284","volume":"282","author":"Nienaber","year":"2015","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib78","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/embo-reports\/kvd016","article-title":"A wheel invented three times. The molecular structures of the three carbonic anhydrases","volume":"1","author":"Liljas","year":"2000","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib79","article-title":"Transcriptome signature of cell viability predicts drug response and drug interaction in Mycobacterium tuberculosis","volume":"1","author":"Srinivas","year":"2021","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/bs.enz.2024.05.012_bib80","article-title":"Carbon dioxide regulates Mycobacterium tuberculosis PhoPR signaling and virulence","author":"Dechow","year":"2022","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/14756366.2019.1683007","article-title":"In vitro inhibition of Mycobacterium tuberculosis beta-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos","volume":"35","author":"Aspatwar","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol. Microbiol."},{"issue":"22","key":"10.1016\/bs.enz.2024.05.012_bib83","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1073\/pnas.2134250100","article-title":"Genetic requirements for mycobacterial survival during infection","volume":"100","author":"Sassetti","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02133-16","article-title":"Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis","volume":"8","author":"DeJesus","year":"2017","journal-title":"mBio"},{"issue":"D1","key":"10.1016\/bs.enz.2024.05.012_bib85","doi-asserted-by":"crossref","first-page":"D384","DOI":"10.1093\/nar\/gkac1096","article-title":"The conserved domain database in 2023","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"26","key":"10.1016\/bs.enz.2024.05.012_bib86","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.96.26.15184","article-title":"Carbonic anhydrase is an ancient enzyme widespread in prokaryotes","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/bs.enz.2024.05.012_bib87","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1074\/mcp.M300060-MCP200","article-title":"Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain","volume":"2","author":"Gu","year":"2003","journal-title":"Mol. Cell Proteom."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib88","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/s41467-021-23588-w","article-title":"RNA atlas of human bacterial pathogens uncovers stress dynamics linked to infection","volume":"12","author":"Avican","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.enz.2024.05.012_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.909904","article-title":"Commonalities of Mycobacterium tuberculosis transcriptomes in response to defined persisting macrophage stresses","volume":"13","author":"Vilch\u00e8ze","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211003","article-title":"Integrated transcriptomic and proteomic analysis of pathogenic mycobacteria and their esx-1 mutants reveal secretion-dependent regulation of ESX-1 substrates and WhiB6 as a transcriptional regulator","volume":"14","author":"Abdallah","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010331","article-title":"PrrA modulates Mycobacterium tuberculosis response to multiple environmental cues and is critically regulated by serine\/threonine protein kinases","volume":"18","author":"Giacalone","year":"2022","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112875","article-title":"MtrA modulates Mycobacterium tuberculosis cell division in host microenvironments to mediate intrinsic resistance and drug tolerance","volume":"42","author":"Peterson","year":"2023","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib93","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio.2259","article-title":"Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence","volume":"13","author":"Zheng","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02944-22","article-title":"Role of the extracytoplasmic function sigma factor SigE in the stringent response of Mycobacterium tuberculosis","volume":"11","author":"Baruzzo","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"518","key":"10.1016\/bs.enz.2024.05.012_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6635","article-title":"Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis","volume":"11","author":"Mishra","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"35","key":"10.1016\/bs.enz.2024.05.012_bib96","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1039\/C6OB01477A","article-title":"Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations","volume":"14","author":"Cau","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"28","key":"10.1016\/bs.enz.2024.05.012_bib97","doi-asserted-by":"crossref","first-page":"25209","DOI":"10.1021\/acsomega.3c02311","article-title":"CanB, a druggable cellular target in Mycobacterium tuberculosis","volume":"8","author":"Degiacomi","year":"2023","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/bs.enz.2024.05.012_bib98","first-page":"169","article-title":"Carbonic anhydrases fused to anion transporters of the SulP family: evidence for a novel type of bicarbonate transporter","volume":"8","author":"Felce","year":"2004","journal-title":"J. Mol. Microbiol. Biotechnol."},{"issue":"11","key":"10.1016\/bs.enz.2024.05.012_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112911","article-title":"Carbonic anhydrase inhibitors as novel drugs against mycobacterial beta-carbonic anhydrases: an update on in vitro and in vivo studies","volume":"23","author":"Aspatwar","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/bs.enz.2024.05.012_bib100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/bs.enz.2024.05.012_bib101","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/14756366.2013.842233","article-title":"Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three beta-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"29","author":"Ceruso","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.012_bib102","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/jm1013242","article-title":"Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases","volume":"54","author":"Davis","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib103","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/14756366.2011.650168","article-title":"Inhibition of the beta-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib104","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1080\/14756366.2018.1471475","article-title":"Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis \u03b2-class enzyme Rv3273","volume":"33","author":"Wani","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.012_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052584","article-title":"Benzothiadiazinone-1,1-dioxide carbonic anhydrase inhibitors suppress the growth of drug-resistant Mycobacterium tuberculosis strains","volume":"25","author":"Bua","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/bs.enz.2024.05.012_bib106","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bmcl.2012.11.085","article-title":"Inhibition of the beta-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity","volume":"23","author":"Buchieri","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib107","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/14756366.2011.645539","article-title":"Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three beta-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/bs.enz.2024.05.012_bib108","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/jm9004016","article-title":"Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273","volume":"52","author":"Guzel","year":"2009","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib109","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","article-title":"Dithiocarbamates strongly inhibit the beta-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"17","key":"10.1016\/bs.enz.2024.05.012_bib110","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1016\/j.bmcl.2009.07.088","article-title":"Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides","volume":"19","author":"Maresca","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/bs.enz.2024.05.012_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020598","article-title":"Evaluation of thio- and seleno-acetamides bearing benzenesulfonamide as inhibitor of carbonic anhydrases from different pathogenic bacteria","volume":"21","author":"Angeli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2024.05.012_bib112","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bioorg.2019.01.065","article-title":"Click-tailed benzenesulfonamides as potent bacterial carbonic anhydrase inhibitors for targeting Mycobacterium tuberculosis and Vibrio cholerae","volume":"86","author":"Bua","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2024.05.012_bib113","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bmcl.2010.11.064","article-title":"Inhibition of beta-carbonic anhydrases with ureido-substituted benzenesulfonamides","volume":"21","author":"Pacchiano","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/bs.enz.2024.05.012_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28104020","article-title":"Inhibition studies on human and mycobacterial carbonic anhydrases with N-((4-sulfamoylphenyl)carbamothioyl) amides","volume":"28","author":"Abdoli","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/bs.enz.2024.05.012_bib115","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1039\/C7MD00090A","article-title":"Dichloro-naphthoquinone as a non-classical inhibitor of the mycobacterial carbonic anhydrase Rv3588c","volume":"8","author":"Dallaston","year":"2017","journal-title":"MedChemComm"},{"issue":"11","key":"10.1016\/bs.enz.2024.05.012_bib116","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1016\/j.bmc.2013.03.077","article-title":"Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine","volume":"21","author":"Aksu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.012_bib117","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3109\/14756366.2016.1172577","article-title":"Anti-tubercular and antioxidant activities of C-glycosyl carbonic anhydrase inhibitors: towards the development of novel chemotherapeutic agents against Mycobacterium tuberculosis","volume":"31","author":"Zaro","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.012_bib118","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1128\/AAC.00719-15","article-title":"The carbonic anhydrase inhibitor ethoxzolamide inhibits the Mycobacterium tuberculosis PhoPR regulon and Esx-1 secretion and attenuates virulence","volume":"59","author":"Johnson","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.012_bib119","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01597-16","article-title":"Identification of bicarbonate as a trigger and genes involved with extracellular DNA export in mycobacterial biofilms","volume":"7","author":"Rose","year":"2016","journal-title":"MBio"},{"issue":"13","key":"10.1016\/bs.enz.2024.05.012_bib120","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0960-894X(01)00266-9","article-title":"Antimycobacterial activity of 9-sulfonylated\/sulfenylated-6-mercaptopurine derivatives","volume":"11","author":"Scozzafava","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.012_bib121","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.bmc.2012.09.002","article-title":"Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases","volume":"21","author":"Riafrecha","year":"2013","journal-title":"Bioorg. Med. Chem."}],"container-title":["The Enzymes","Bacterial Carbonic Anhydrases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187460472400012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187460472400012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:21:07Z","timestamp":1725088867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187460472400012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443295188"],"references-count":121,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2024.05.012","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}